Certificate Number

GMPC or Non Compliance

Site Name

Site Address

City

Postcode

Country

Total Records 1561 to 1570 of 1631
Download
GMP Search Results
Certificate Number GMPC or Non-compliance Site Details Country Inspection Date
UK GMP 37064 Insp GMP 37064/1926523-0001[H] GMPC

INTEGRA CI INCORPORATED, STATE ROAD 402 NORTH, KM 1.2, ANASCO, PR-00610, PUERTO RICO

PUERTO RICO
UK GMP 35774 Insp GMP 35774/700608-0002[H] GMPC

AAI PHARMA SERVICES CORPORATION, STABILITY, CLINICAL SUPPLIES, GENERAL WAREHOUSE, 1519 N 23RD STREET, WILMINGTON, 28405, UNITED STATES

UNITED STATES
UK GMP 20096 Insp GMP 20096/13049-0004[H] GMPC

EGYPTIAN INTERNATIONAL PHARMACEUTICALS INDUSTRIES CO (EIPICO), INDUSTRIAL ZONE B1, TENTH OF RAMADAN CITY, EG 19290, EGYPT

EGYPT
UK GMP 35774 Insp GMP 35774/700612-0002[H] GMPC

AAI PHARMA SERVICES CORPORATION, ANALYTICAL SERVICES, 1717 HALL DRIVE, WILMINGTON, 28405, UNITED STATES

UNITED STATES
UK GMP 35774 Insp GMP 35774/700610-0002[H] GMPC

AAI PHARMA SERVICES CORPORATION, ANALYTICAL, FORMULATIONS DEVELOPMENT, 1206 N 23RD STREET, WILMINGTON, 28405, UNITED STATES

UNITED STATES
UK MIA(IMP) 11387 Insp GMP/IMP 11387/1453-0006[I] GMPC

PHARMACEUTICAL QUALITY ASUURANCE LABORATORY, PHARMACY PRODUCTION UNIT, ST THOMAS' HOSPITAL, WESTMINSTER BRIDGE ROAD, LONDON, SE1 7EH, UNITED KINGDOM

UNITED KINGDOM
UK GMP 21847 Insp GMP 21847/23796-0005[H] GMPC

DEY PHARMA LP, 2751 NAPA VALLEY CORPORATE DRIVE, NAPA, 94558, UNITED STATES

UNITED STATES
UK GMP 32392 Insp GMP 32392/443877-0002[H] GMPC

PHILLIPS PLASTICS CORPORATION, ORIGEN CENTER, 428 TECHNOLOGY DRIVE EAST, MENOMONIE, 54751, UNITED STATES

UNITED STATES
UK GMP 26502 Insp GMP 26502/109511-0001[H] GMPC

NEPHRON PHARMACEUTICALS CORPORATION, 4121 SW 34TH STREET, ORLANDO, 32811, UNITED STATES

UNITED STATES
UK GMP 36456 Insp GMP/IMP 36456/1523938-0001 [H] GMPC

CATALENT NOTTINGHAM LIMITED, 8 ORCHARD PLACE, NOTTINGHAM BUSINESS PARK, NOTTINGHAM, NG8 6PX, UNITED KINGDOM

UNITED KINGDOM

Due to the restrictions caused by COVID-19, the period of validity GMP and GDP certificates issued by MHRA is automatically extended until the end of 2024, except where clarifying remarks in the document state otherwise. Manufacturers, importers and distributors must continue to comply with GMP/GDP and all other legal obligations. On-site inspections are now being conducted and scheduling of these inspections may be independent of the extended validity period stated above. MHRA reserve the right to perform risk based supervision of sites by either on-site inspections or distant assessments and, based on the outcome, may continue to issue, withdraw or restrict GMP and GDP certificates, as appropriate.

Download XLSX